Skip to main content

Medicare unveils plan for coverage of new Alzheimer’s drugs

Patient registry could be a barrier to coverage of new treatments, critics say.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.